“The lower the amount of an antibody you can deliver to someone, the easier it will be to manufacture a treatment, and the ...
New research led by scientists at La Jolla Institute for Immunology (LJI) reveals the workings of a human antibody called mAb 3A6, which may prove to be an important component for Ebola virus ...
New research led by scientists at La Jolla Institute for Immunology (LJI) reveals the workings of a human antibody called mAb ...
This research comes as dengue-carrying mosquitos expand their territory into new regions, including Southern California.
Scientists at La Jolla Institute for Immunology (LJI) have found a potential new target for treating Parkinson's disease.
Children who experience multiple cases of dengue virus develop an army of dengue-fighting T cells, according to a new study led by scientists at La Jolla Institute for Immunology (LJI).